We are live on
!
Find out more
TCM
Traynor Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
62.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
(+3.8%)
Cap. Flow
+$4.27M
Cap. Flow
% of AUM
2.03%
Top 10 Holdings %
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$840K |
| 2 |
Apple
AAPL
|
+$728K |
| 3 |
Altria Group
MO
|
+$501K |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$439K |
| 5 |
Snap
SNAP
|
+$408K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$516K |
| 2 |
Amazon
AMZN
|
+$363K |
| 3 |
Qualcomm
QCOM
|
+$343K |
| 4 |
Vulcan Materials
VMC
|
+$287K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$239K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.78% |
| 2 | Communication Services | 11.14% |
| 3 | Healthcare | 9.45% |
| 4 | Consumer Discretionary | 7.27% |
| 5 | Industrials | 5.86% |
Similar funds
SIG
ICM
PVI
SCP
OWP
CAG
ET
SQA
Traynor Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.
- Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
- Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
- Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
- Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
- Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
- Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
- Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.
Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.